热门资讯> 正文
Matinas BioPharma收到纽约证券交易所不合规通知
2025-01-11 06:23
- Matinas BioPharma (NYSE:MTNB) said on Friday that it has received an NYSE American notice indicating that the company has fallen below certain NYSE American continued listing standards because it failed to hold its annual meeting of stockholders for the fiscal year ending on December 31, 2024.
- The company intends to hold its annual meeting no later than December 31, 2025 to regain compliance under the NYSE American Company Guide.
- Matinas BioPharma (NYSE:MTNB) shares were down 3.21% in post market trading on Friday.
More on Matinas Biopharma
- Matinas BioPharma plunges as deal for lead asset falls apart
- Seeking Alpha’s Quant Rating on Matinas Biopharma
- Historical earnings data for Matinas Biopharma
- Financial information for Matinas Biopharma
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
